sunitinib/axitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for sunitinib/axitinib, covering 2022-02-18 to 2022-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.